Cargando…
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
PURPOSE: To review published data pertaining to the clinical experience with a dexamethasone intravitreal implant (Ozurdex®) with a view to establishing a clinically based therapeutic regime. METHODS: A PubMed search using the MeSH terms “retinal vein occlusion” and either “pathophysiology” or “dexa...
Autores principales: | Garweg, Justus G., Zandi, Souska |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917582/ https://www.ncbi.nlm.nih.gov/pubmed/27178087 http://dx.doi.org/10.1007/s00417-016-3350-x |
Ejemplares similares
-
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients: Corneal endothelium after dexamethasone implant injection
por: Güler, Hatice Ayhan, et al.
Publicado: (2018) -
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex(®)) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
por: Chan, Annie, et al.
Publicado: (2011) -
Intravitreal Dexamethasone Implant (Ozurdex) in Coats’ Disease
por: Saatci, Ali Osman, et al.
Publicado: (2013) -
Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
por: Örnek, Nurgül, et al.
Publicado: (2016) -
Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
por: Aljohani, Saud M., et al.
Publicado: (2021)